Navigation Links
The many facets of milk and its health potential

It is well known how nutritional dense milk is so there is study in Australia to explore and to develop valuable new products with nutraceutical, pharmaceutical and agrochemical potential.//

This has been initiated in The University of Queensland's Institute for Molecular Bioscience (IMB) and the Sydney-based Australian R&D company. Microbial Screening Technologies (MST) has teamed up with MG Nutritionals for the search for utilising the unique biologically active compounds (bioactives) in milk.

Regarding the collaborators, Murray Goulburn Co-operative was formed in 1950 and has grown to become the largest processor of milk in Australia and the nation's largest exporter of processed food. IMBcom Pty Ltd, the University's commercialisation company for the IMB, has signed research agreement with MG Nutritionals.

CEO of IMBcom said,”The agreement set the foundation for the discovery of new bioactives. The Institute had Australia's largest and best-equipped laboratory to discover and develop drugs from any source - including milk.”

This collaboration has become a force to reckon with in microbiology, chemistry, molecular biology with the largest processor of milk in Australia, Murray Goulburn.

The General Manager of MG Nutritionals said,” This alliance provided MG Nutritionals access to world class expertise in the biodiscovery field.”

According to GM of Nutritionals "Milk is a rich source of unique and complex biological molecules and we believe it has the potential to stimulate microbial metabolism, thereby allowing access to unexplored bioactive molecular structures,"

Stated by Prof. Mattick, "This strategic national alliance builds on the potential, capacity and strengths of the IMB as an internationally competitive research organisation meeting the industry demand for commercially driven relevant outcomes,"
'"/>




Page: 1

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Debate Rages over firing of HIV infected health care workers
3. Patient’s perception of health status helps in better recover
4. Antioxidants protect health tissue in people undergoing radiation therapy.
5. Sexual abuse affect health for a lifetime
6. Smoking a greater risk than HIV? Yes say health experts!!!!
7. How much can exercise improve health?
8. Bald head bad health
9. Drink grape juice for health
10. For healthy lungs
11. Borderline blood pressure- possible health risk
Post Your Comments:
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
..., April 24 Prime Therapeutics (Prime), a,thought ...oday that,Rachelle Wan, RPh, has joined the organi...ns., As Vice President of Pharmacy Trade Relation...rategic pharmacy,contracts and the performance of ...
...April 24 Life Brokerage Partners,announces three ...ms with,Peach Holdings, Inc. ("Peachtree"), Polari...premium finance programs are particularly valuable... and UNF,do not end with the agents, but extend to...
... Reveals Americans Are in Overdrive, Trend Exper...s Expert Denise Austin Offers Nightl...fter a long day at the,office, do you reach for yo...er than ever before, often at the expense of,their...
..., N.J., April 24 Cambrex,Corporation (NYSE: CBM ...8,financial results on Thursday, May 1, 2008 after...i-bin/prnh/20000613/CAMBREXLOGO ), The Company w... Thursday, May 1, 2008 at 5:00 p.m. Easter...
...homa Society and Ralph Lauren Center for Cancer Ca...Be Certified, NEW YORK, April 24 The Harold P. F...d that representatives from the Leukemia,& Lymphom...nic were the first to be trained in patient naviga...
...l 23 Young Innovations, Inc.,(Nasdaq: YDNT ) tod...1,2008., Sales for the first quarter of 2008 were...% from the $22.9 million reported in the first qua...come,was essentially unchanged at $2.8 million, co...
Other Medicine News:Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 2Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 3Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 5Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 6Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 5
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: